KBC Group NV

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1411133 Brussels, C9

Back to VRTX Full portfolio

Position in VRTX

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$56,803,459

-$7,174,703 QoQ

Shares Held

127,208

-9.9% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

KBC Group NV holds $172,610,851 across 111 Biotechnology names. VRTX ranks #1 (32.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	127,208	$56,803,459
2	REGN	Regeneron Pharmaceuticals, Inc.	38,473	$29,725,778
3	JAZZ	Jazz Pharmaceuticals plc	102,199	$19,320,720
4	XENE	Xenon Pharmaceuticals Inc.	129,010	$7,501,931
5	BMRN	Biomarin Pharmaceutical Inc	127,194	$7,185,189
6	ALNY	Alnylam Pharmaceuticals, Inc.	20,524	$6,790,774
7	INSM	INSMED Inc	37,347	$6,106,981
8	CRSP	CRISPR Therapeutics AG	116,847	$5,558,411

All Filings in VRTX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$56,803,459	127,208	-9.9%	Shares	Defined	2026-05-07
2025-12-31	$63,978,162	141,120	+5.6%	Shares	Defined	2026-01-26
2025-09-30	$52,323,886	133,602	+0.7%	Shares	Defined	2026-01-20
2025-06-30	$59,062,457	132,665	+11.2%	Shares	Defined	2025-08-08
2025-03-31	$57,841,449	119,305	-0.1%	Shares	Defined	2025-04-25
2024-12-31	$48,094,057	119,429	+23.5%	Shares	Defined	2025-01-22
2024-09-30	$44,985,792	96,727	+11.1%	Shares	Defined	2024-11-06
2024-06-30	$40,798,326	87,042	+5.9%	Shares	Defined	2024-07-17
2024-03-31	$34,348,717	82,172	-18.9%	Shares	Defined	2024-05-08
2023-12-31	$41,207,377	101,274	+0.9%	Shares	Defined	2024-02-13
2023-09-30	$34,913,095	100,400	-53.7%	Shares	Defined	2024-02-15
2023-06-30	$76,321,536	216,878	+12.9%	Shares	Defined	2024-02-15
2023-03-31	$60,518,015	192,078	-24.5%	Shares	Defined	2024-02-14
2022-12-31	$73,444,550	254,327	+0.1%	Shares	Defined	2024-02-14
2022-09-30	$73,535,920	253,975	-12.4%	Shares	Defined	2024-02-15
2022-06-30	$81,712,336	289,976	+4.1%	Shares	Defined	2024-02-14
2022-03-31	$72,664,225	278,439	-52.4%	Shares	Defined	2024-02-14
2021-12-31	$128,521,778	585,254	+108.9%	Shares	Defined	2024-02-14
2021-09-30	$50,818,766	280,163	-5.4%	Shares	Defined	2021-11-10
2021-06-30	$59,711,917	296,146	+17.0%	Shares	Defined	2022-02-15
2021-03-31	$54,370,178	253,014	+3.4%	Shares	Defined	2022-02-14
2020-12-31	$57,807,818	244,596	+65.0%	Shares	Defined	2022-02-14
2020-09-30	$40,333,081	148,218	+21.2%	Shares	Defined	2022-02-14
2020-06-30	$35,490,107	122,249	+23.2%	Shares	Defined	2022-02-14
2020-03-31	$23,614,157	99,240	—	Shares	Defined	2020-05-04
No filing history on record for this holder in this stock.